Exclusive interview with Dilip Singh Rathod, President India Business, JB Pharma
In this interview, Dilip Singh Rathod, President: India Business, JB Pharma, offers insights into the company's India growth…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
JB Pharma
Pharma sector gears up for Budget 2025-26; urges for strong regulatory framework and faster approval…
Industry leaders share their expectations from the upcoming Union budget 2025-26. Increased allocation for R&D and…
JB Pharma announces ESG commitments with launch of third sustainability report
JB Pharma outlines goals to reduce emissions, increase renewable energy use, and achieve water positivity by 2033 in its latest…
Industry lauds Union Budget’s focus on Women’s Health
Overall, the Union Budget 2024 reflects a forward-looking approach
OPPI commends the Government's approach towards the healthcare…
JB Pharma inks Rs 1,089 crore pact with Novartis for select ophthalmology brands
On the financial details of the agreements, JB Pharma said it will pay USD 116 million (Rs 964 crore), excluding applicable taxes,…
JB Pharma reports revenue growth of 9 per cent to Rs 882 crores in Q2 FY24
PAT increased by 36 per cent to Rs 151 crores
JB Pharma publishes its second ESG report for FY 2022-23
JB Pharma reported 19 per cent decrease in GHG intensity as compared to last year
JB Pharma launches knowledge based app for doctors
The app grants young & upcoming post-graduate doctors access to a wealth of medical and non-medical information, equipping…
USFDA inspects JB Pharma’s manufacturing facility at Panoli, Gujarat
The facility received no observations and no Form 483 was issued
JB Pharma: Betting big on India
Our biggest bet is India and the CDMO space, says Nikhil Chopra, CEO, JB Pharma, taking stock of the company's ongoing transition…